phenytoin
Generic: phenytoin
Labeler: taro pharmaceuticals u.s.a., incDrug Facts
Product Profile
Brand Name
phenytoin
Generic Name
phenytoin
Labeler
taro pharmaceuticals u.s.a., inc
Dosage Form
TABLET, CHEWABLE
Routes
Active Ingredients
phenytoin 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51672-4146
Product ID
51672-4146_1aa91dac-0e01-46c6-bc45-93b08e84574c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA200565
Listing Expiration
2026-12-31
Marketing Start
2014-04-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516724146
Hyphenated Format
51672-4146
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
phenytoin (source: ndc)
Generic Name
phenytoin (source: ndc)
Application Number
ANDA200565 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-1)
- 1000 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-3)
- 30 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-6)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1aa91dac-0e01-46c6-bc45-93b08e84574c", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "unii": ["6158TKW0C5"], "rxcui": ["1313885"], "spl_set_id": ["78b38e7b-1460-4adc-b738-320ffa6259c2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-1)", "package_ndc": "51672-4146-1", "marketing_start_date": "20140417"}, {"sample": false, "description": "1000 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-3)", "package_ndc": "51672-4146-3", "marketing_start_date": "20140417"}, {"sample": false, "description": "30 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-6)", "package_ndc": "51672-4146-6", "marketing_start_date": "20140417"}], "brand_name": "Phenytoin", "product_id": "51672-4146_1aa91dac-0e01-46c6-bc45-93b08e84574c", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4146", "generic_name": "Phenytoin", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin", "active_ingredients": [{"name": "PHENYTOIN", "strength": "50 mg/1"}], "application_number": "ANDA200565", "marketing_category": "ANDA", "marketing_start_date": "20140417", "listing_expiration_date": "20261231"}